CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Daily summary: Pfizer failed to trigger a new wave of growth

19:49 8 December 2021

Today's session did not really bring much volatility to the markets. The most key news of the day seems to have been about coronavirus vaccines from Pfizer, the first company to release a vaccine on the market. The initial information coming from the company was not clear, but eventually it was communicated that two and three doses of the vaccine should be good cover against the new coronavirus variant. Nevertheless, Pfizer still announced that it will work on a new variant of the vaccine, also geared towards Omicron, within the next months. The market reacted very positively to this news and many indices were then at daily peaks. Later, however, these gains were given back and many indices today closed the day with declines.

On Wall Street, the situation has improved compared to the start of the session and only the Dow Jones is currently slightly negative. Travel stocks gained today, although it is also worth noting another rebound in technology companies. There is still a chance of a Santa Claus Rally, although not all indices have yet recovered from the appearance of a new strain of coronavirus.

Start investing today or test a free demo

Open account Try demo Download mobile app Download mobile app

The oil market has also behaved quite mixed. There are conflicting messages coming out of OPEC+ and it is difficult to forecast what the next steps from the cartel will be. The price rebounded today, but received a slight blow from a weak DOE report on oil inventories. Oil inventories fell, but very little, by less than 300,000 bbl alone. Seasonality indicates that end of year inventories tend to be stable. Stocks of petroleum products rose very sharply for the second week in a row, which may raise concerns about real demand. However, oil processing has increased and stocks are rising from very low levels, mostly from at least 5-year lows.

Expectations of interest rate rises have fallen in the UK amid the announcement of more restrictions. The chances of a December hike are diminishing, although there is still a chance. Goldman Sachs has pushed back its forecast to February. The announced restrictions, however, did not turn out to be very severe, from the point of view of the economy.

The Bitcoin price is currently holding above the key $50,000 support. Ethereum is dominating and getting closer and closer to historical highs. The global cryptocurrency market capitalization sits at 2.38 trillion dollars today.

This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.

Xtb logo

Join over 1 Million investors from around the world

We use cookies

By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

This group contains cookies that are necessary for our websites to work. They take part in functionalities like language preferences, traffic distribution or keeping user session. They cannot be disabled.

Cookie name
userBranchSymbol cc 2 March 2024
adobe_unique_id cc 1 March 2025
test_cookie cc 1 March 2024
SESSID cc 9 September 2022
__hssc cc 1 March 2024
__cf_bm cc 1 March 2024
intercom-id-iojaybix cc 26 November 2024
intercom-session-iojaybix cc 8 March 2024

We use tools that let us analyze the usage of our page. Such data lets us improve the user experience of our web service.

Cookie name
_gid cc 9 September 2022
_gat_UA-22576382-1 cc 8 September 2022
_gat_UA-121192761-1 cc 8 September 2022
_ga_CBPL72L2EC cc 1 March 2026
_ga cc 1 March 2026
AnalyticsSyncHistory cc 8 October 2022
af_id cc 31 March 2025
afUserId cc 1 March 2026
af_id cc 1 March 2026
AF_SYNC cc 8 March 2024
__hstc cc 28 August 2024

This group of cookies is used to show you ads of topics that you are interested in. It also lets us monitor our marketing activities, it helps to measure the performance of our ads.

Cookie name
MUID cc 26 March 2025
_omappvp cc 11 February 2035
_omappvs cc 1 March 2024
_uetsid cc 2 March 2024
_uetvid cc 26 March 2025
_fbp cc 30 May 2024
fr cc 7 December 2022
muc_ads cc 7 September 2024
_ttp cc 26 March 2025
_tt_enable_cookie cc 26 March 2025
_ttp cc 26 March 2025
hubspotutk cc 28 August 2024

Cookies from this group store your preferences you gave while using the site, so that they will already be here when you visit the page after some time.

Cookie name
personalization_id cc 7 September 2024
UserMatchHistory cc 8 October 2022
bcookie cc 8 September 2023
lidc cc 9 September 2022
bscookie cc 8 September 2023
li_gc cc 7 March 2023

This page uses cookies. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. For more information see our Privacy Policy You can manage cookies by clicking "Settings". If you agree to our use of cookies, click "Accept all".

Change region and language
Country of residence